Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
ILT4 functions as a potential checkpoint molecule for tumor immunotherapy
Aiqin Gao
, Yuping Sun
,
Guangyong Peng
Department of Otolaryngology
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
DBBS - Cancer Biology
DBBS - Immunology
DBBS - Neurosciences
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
Research output
:
Contribution to journal
›
Review article
›
peer-review
50
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'ILT4 functions as a potential checkpoint molecule for tumor immunotherapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Antitumor Immune Response
12%
Biological Behavior
12%
Cancer Immunotherapy
12%
Cancer Types
25%
Cell-to-cell
12%
Checkpoint Molecules
100%
Clinical Success Rate
12%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
12%
Dendritic Cells
12%
Functional Role
12%
Granulocytes
12%
Immune Checkpoint
12%
Immune Checkpoint Therapy
12%
Immune Escape
12%
Immunoglobulin-like Transcript 4
100%
Immunosuppressive Molecules
12%
In Cancer
12%
Malignancy
12%
Microenvironment
12%
Monocyte-derived Macrophages
12%
Myeloid Cells
12%
Programmed Death-ligand 1 (PD-L1)
12%
Promising Strategies
12%
Stroma Cells
12%
Tolerogenic
12%
Tumor Cells
25%
Tumor Development
12%
Tumor Immunotherapy
100%
Tumor Malignant Behavior
12%
Tumor Microenvironment
12%
Tumor Pathogenesis
12%
Tumor Progression
12%
Tumor Stroma
12%
Tumor Suppression
12%
Tumor-promoting
12%
Immunology and Microbiology
Cancer Immunotherapy
100%
Dendritic Cell
12%
Granulocyte
12%
Immune Checkpoint Blockade
12%
Immune Escape
12%
Immune Response
12%
Immunosuppressive Drug
12%
Intravenous Immunoglobulin
100%
Macrophage
12%
Myeloid
12%
Programmed Death-Ligand 1
12%
Stroma Cell
12%
Tumor Cell
25%